Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene

Clinical Genetics

Volumn 56, Issue 4, 1999, Pages 289-296

  Hubel, Carl A ^a   Roberts, James M ^a   Ferrell, Robert E ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetics; Lipoprotein lipase; Pre eclampsia; Pregnancy

Indexed keywords

LIPID; LIPOPROTEIN LIPASE;

ADULT; ARTICLE; ASSAY; CARDIOVASCULAR DISEASE; CAUCASIAN; CONTROLLED STUDY; DYSLIPIDEMIA; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MISSENSE MUTATION; PREECLAMPSIA; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; BLOOD PRESSURE; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HELLP SYNDROME; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEIN LIPASE; MUTATION, MISSENSE; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES;

EID: 0032697526     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.1999.560406.x     Document Type: Article

References (43)

1. Chesley LC. Hypertension in pregnancy: definitions, familial factor, and remote prognosis. Kidney Int 1980: 18: 234-240.
2. Arngrímsson R, Geirsson RT, Bjornsson S, Bjornsson H, Walker JJ, Snaedal G. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Brit J Obstet Gynaecol 1990: 97: 762-769.
3. Cooper DW, Brennecke SP, Wilton AN. Genetics of pre-eclampsia. Hypertens Pregnancy 1993: 12: 1-23.
4. Roberts JM. Endothelial dysfunction in pre-eclampsia. Semin Reprod Endocrinol 1998: 16: 5-15.
5. Ness RB, Roberts JM. Heterogeneous causes constituting the single syndrome of pre-eclampsia: a hypothesis and its implications. Am J Obstet Gynecol 1996: 175: 1365-1370.
6. Hubel CA. Dyslipidemia, iron, and oxidative stress in pre-eclampsia: assessment of marternal and feto-placental interactions. Semin Reprod Endocrinol 1998: 16: 75-92.
7. Kaaja R. Insulin resistance syndrome in pre-eclampsia. Seminars Reprod Endocrinol 1998: 16: 41-46.
8. Lorentzen B, Henriksen T. Plasma lipids and vascular dysfunction in pre-eclampsia. Semin Reprod Endocrinol 1998: 16: 33-39.
9. Lorentzen B, Drevon CA, Endressen MJ, Henriksen T. Fatty acid pattern of esterfied and free fatty acids in sera of women with normal and pre-eclamptic pregnancy. Brit J Obstet Gynaecol 1995: 102: 530-537.
10. Gratacos E, Casals E, Sanllehy C, Cararach V, Alonso PL, Fortuny A. Variation in lipid levels during pregnancy in women with different types of hypertension. Acta Obstet Gynecol Scand 1996: 75: 896-901.
11. Sattar N, Bedomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in pre-eclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol 1997: 89: 403-408.
12. Hubel CA, Lyall F, Weissfeld L, Gandley RE, Roberts JM. Small low-density lipoproteins and vascular cell adhesion molecule (VCAM-1) are increased in association with hyperlipidemia in pre-eclampsia. Metabolism 1998: 47: 1281-1288.
13. Eckel R, Yost T, Jensen E. Alterations in lipoprotein lipase in insulin resistance. Internal J Obesity 1995: 19: S16-S21.
14. Fisher RM, Humphries SE, Talmud PJ. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis 1997: 135: 145-159.
15. Syvanne M, Antikainen M, Ehnholm S, Tenkanen H, Lahdenpera S, Ehnholm C, Taskinen MR. Heterozygosity for Asn291 → Ser mutation in the lipoprotein lipase gene in two Finnish pedigrees: effect of hyperinsulinemia on the expression of hypertriglyceridemia. J Lipid Res 1996: 37: 727-738.
16. Ma Y, Ooi TC, Liu MS, Zhang H, McPherson R, Edwards AL, Forsythe IJ, Frohlich J, Brunzell JD, Hayden MR. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res 1994: 35: 1066-1075.
17. Talmud PJ, Hall S, Holleran S, Ramakrishnan R, Ginsberg HN, Humphries SE. LPL promoter -93T/G transition influences fasting and postprandial plasma triglycerides response in African-Americans and Hispanics. J Lipid Res 1998: 39: 1189-1196.
18. Hall S, Chu G, Miller G, Cruickshank K, Cooper JA, Humphries SE, Talmud PJ. A common mutation in the lipoprotein lipase gene promoter, - 93T/G, is associated with lower plasma triglyceride levels and increased promoter activity in vitro. Arterioscler Thromb Vase Biol 1997: 17: 1969-1976.
19. Ehrenborg E, Clee SM, Pimstone SN, Reymer PWA, Benlian P, Hoogendijk CF, Davis HJ, Bissada N, Miao L, Gagne SE, Greenberg LJ, Henry R, Henderson H, Ordovas JO, Schaefer EJ, Kastelein JJP, Kotze MJ, Hayden MR. Ethnic variation and in vivo effects of the -93t-g promotor variant in the lipoprotein lipase gene. Arterioscler Thromb Vasc Biol 1997: 17: 2672-2678.
20. Kastelein JJP, Groenemeyer BE, Hallman DM, Henderson H, Reymer PWA, Gagné SE, Jansen H, Seidell JC, Kromhout D, Jukema JW, Bruschke AVG, Boerwinkle E, Hayden MR. The Asn9 variant of lipoprotein lipase is associated with the - 93G promoter mutation and an increased risk of coronary artery disease. Clin Genet 1998: 53: 27-33.
21. Kuivenhoven JA, Groenemeyer BE, Boer JMA, Reymer PWA, Berghuis R, Bruin T, Jansen H, Seidell JC, Kastelein JJP. Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler Thromb Vasc Biol 1997: 17: 595-599.
22. Sibai BM. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990: 162: 311-316.
23. Kirchgessner TG, Chuat JC, Heinzmann C, Etienne J, Guilhot S, Svenson K, Ameis D, Pilon C, d'Auriol L, Andalibi A. Organization of the human lipoprotein lipase gene and evolution of the lipase gene family. Proc Natl Acad Sci USA 1989: 86: 9647-9651.
24. Monsalve MV, Henderson H, Roederer G, Julien P, Deeb S, Kastelein JJP, Peritz L, Devlin R, Bruin T, Murthy MRV, Cagne C, Davignon J, Lupien PJ, Brunzell JD, Hayden MR. A missense mutation at codon 188 of the human lipoprotein lipase gene is a frequent cause of lipoprotein lipase deficiency in persons of different ancestries. J Clin Invest 1990: 86: 728-734.
25. Faustinella F, Chang A, Van Biervliet JP, Rosseneu M, Vinaimont N, Smith LC, Chen S-H, Chan L. Catalytic triad residue mutation (Asp156-Gly) causing familial lipoprotein lipase deficiency. J Biol Chem 1991: 266: 14418-14424.
26. Nickerson DA, Kaiser R, Lappin S, Stewart J, Hood L, Lundgren U. Automated DNA diagnostics using an ELISA-based oligonucleotide ligation assay. Proc Nat Acad Sci USA 1990: 87: 2923-2927.
27. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder AFW, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud PJ. A common variant in the gene for lipoprotein lipase (Asp9 → Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995: 15: 468-478.
28. Reymer P, Gagné E, Groenemeyer B, Zhang H, Forsyth I, Jensen H, Seidell J, Kromhout D, Lie K, Kastelein J, Hayden M. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet 1995: 10: 28-33.
29. Wittrup HH, Tybjaerg-Hansen A, Abildgard S, Steffensen R, Schnohr P, Nordestgaard BG. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest 1997: 99: 1606-1613.
30. Campos H, Dreon DM, Krauss RM. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low density lipoprotein subclasses. J Lipid Res 1995: 36: 462-472.
31. Jukema J, vanBoven J, Groenemeijer B, Zwinderman A, Reiber J, Bruschke A, Henneman J, Molhoek G, Bruin T, Jansen H, Gagné E, Hayden M, Kastelein J. The Asp9Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation 1996: 94: 1913-1918.
32. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int J Clin Lab Res 1997: 27: 24-34.
33. Arngrímsson R, Bjornsson H, Geirsson RT. Analysis of different inheritance patterns in pre-eclampsia/eclampsia syndrome. Hypertens Pregnancy 1995: 14: 27-38.
34. Ward K, Lindheimer MD. Genetic factors. In: Lindheimer MD, Roberts JM. Cunningham FG, eds. Chesley's Hypertensive Disorders in Pregnancy, 2nd ed. Stamford, Connecticut: Appleton & Lange, 1999: 431-452.
35. Hegele RA. The genetic basis of atherosclerosis. Int J Clin Lab Res 1997: 27: 2-13.
36. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ. Interaction of the lipoprotein lipase asparagine 291-serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidemic subjects, myocardial infarction survivors, and healthy adults. J Lipid Res 1995: 36: 2104-2112.
37. Hokanson JE, Brunzell JD, Jarvik GP, Wijsman EM, Austin MA. Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency. Am J Hum Genet 1999: 64: 608-618.
38. Sattar N, Gaw A, Packard CJ, Greer IA. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Brit J Obstet Gynaecol 1996: 103: 614-620.
39. Lewis GF, Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes Metab Rev 1996: 12: 37-56.
40. Kupfermine MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, Fait G, Lessing JB. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999: 340: 9-13.
41. Dizon-Townson DS, Nelson LM. Easton K., Ward K. The factor V Leiden mutation may predispose women to severe pre-eclampsia. Am J Obstet Gynecol 1996: 175: 902-905.
42. DeBruin TWA, Mailly F, VanBarlingen HHJJ, Fisher R, Castro M, Talmud CP, Dallinga-Thie GM, Humphries SE. Lipoprotein lipase gene mutations D9N and N291S in four pedigrees with familial combined hyperlipidemia. Eur J Clin Invest 1996: 26: 631-639.
43. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995: 74: 772-776.